CreditRiskMonitor is a financial risk analysis and news service for credit, supply chain and financial professionals.  Our strength in coverage spans 58,000 global public companies, totaling about $70 trillion in corporate revenue.  We also offer solutions that can help ease private company financial risk assessment.  Leading corporations around the world – including more than 35% of the Fortune 1000, plus thousands more worldwide – rely on us to help them stay ahead of financial risk quickly, accurately and cost-effectively. 

A partial report preview for Merz Holding GmbH & Co KG (OLD) is shown below.  Where indicated by "Yes," CreditRiskMonitor contains this information in its extensive database.  To get access to the full report and learn more about CreditRiskMonitor's robust financial risk analysis and timely news service, request a personalized demo and free trial today.

If you are already a subscriber and want to access the full report, click here.

Merz Holding GmbH & Co KG (OLD)
ECKENHEIMER LANDSTRASSE 100
Phone: +49 6915031p:+49 6915031 FRANKFURT AM MAIN, 60318  Germany Fax: +49 691503200f:+49 691503200
Business Summary
Merz Pharma GmbH & Co. KGaA operates as a pharmaceutical company. It is engaged in the research, development, and marketing of drugs for the treatment of neurological and psychiatric diseases. It provides research and development of drugs for the treatment of Alzheimer’s, Parkinson’s, and depression diseases. The Company also offers dermatology products for the treatment of scars, acne, hair loss, and fungal diseases, as well as therapies for liver disease and lipid metabolism disorders. It also offers the first botulinum toxin that is free of complex proteins for treating neurological movement disorders. In the Consumer Products segment, Merz Consumer Care is a provider of OTC medication, dietary supplements and skincare products. The Company generated revenue of EUR 980 million in fiscal year 2012/13.

Scores and Ratings
FRISK®
Score		 Z''
Score		 PAYCE®
Score		 DBT
Index		 Moody's
Rating		 Fitch
Rating		 DBRS
Rating
-Yes-Yes---

Financials, News and Filings
Latest
Statement		 Last
Audit
News		 SEC
Filings		 Bankruptcy
Filings		 Suit &
Judgment
Filings		 Tax
Lien
Filings
6/30/20136/30/2013Yes----

Industries
SIC Code Description
2834 Pharmaceutical preparations
8731 Commercial physical and biological research
6719 Offices of holding companies, not elsewhere classified

Officers and Directors

Title
Name
Age		 Title
Date		 Start
Date
Chairman AndreasKrebs
Spokesman and Chief Executive Officer PhilipBurchard

Business Names
Business Name
BioteCon Therapeutics GmbH
Georg Simons GmbH
M Pharma de Mexico Servicios, S.A. de C.V.
26 additional Business Names available in full report.

General Information
Number of Employees: 2,443 (As of 6/30/2013)
Fax Number: +49 691503200
Email Address: jobs@merz.de


Copyright © 2023 CreditRiskMonitor.com (Ticker: CRMZ). All rights reserved.     
By using this website, you accept the Terms of Use Agreement.
Friday, July 21, 2023